Exton, Pennsylvania-based West Pharmaceutical Services, Inc. (WST) designs, manufactures, and sells containment and delivery systems for injectable drugs and healthcare products. It is valued at a market cap of $22.4 billion.
This healthcare company has considerably outperformed the broader market over the past 52 weeks. Shares of WST have soared 54.1% over this time frame, while the broader S&P 500 Index ($SPX) has gained 27.4%. Moreover, on a YTD basis, the stock is up 15.2%, compared to SPX’s 8.8% rise.